Connect with us

Health

U.S. FDA’s Hahn plans ‘significant’ work with AstraZeneca in COVID-19 trial inquiry – Reuters

The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc’s U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do “very significant work” with the company as it conducts its investigation after an illness in…

Published

on

By Reuters Staff
FILE PHOTO: A sign at an AstraZeneca site in Macclesfield, Britain, May 19, 2014. REUTERS/Phil Noble/File Photo
(Reuters) – The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plcs U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do very significant work with the company as it conducts its investigation after an illness in a participant in Britain.
Were here to protect the American public and were going to do very signif…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending